PharmiWeb.com - Global Pharma News & Resources
26-Feb-2020

MediClin AG: Group sales increased by 4,3 % up to EUR 673.1 mill. - preliminary Group-EBIT amounts to EUR 22.4 mill.

DGAP-News: MediClin AG / Key word(s): Preliminary Results
26.02.2020 / 15:32
The issuer is solely responsible for the content of this announcement.

Group sales increased by 4,3 % up to EUR 673.1 mill. - preliminary Group-EBIT amounts to EUR 22.4 mill.

MEDICLIN Aktiengesellschaft (MEDICLIN) has achieved Group sales of EUR 673.1 mill. (previous year: EUR 645.1 mill.) in the 2019 financial year. Sales plus amounts to EUR 28.0 mill or 4.3 %.

The preliminary Group EBIT accounts for EUR 22.4 mill. (previous year: EUR 15.1 mill.).

The preliminary total consolidated result shows 9.7 mill. (previous year: 7.8 mill.). The preliminary earnings per share is EUR 0.20 (previous year: EUR 0.16).

Sales increase in the post-acute and acute segment

In the post-acute segment sales increased by EUR 16.2 mill. or 4.1 % from EUR 400.5 mill. up to EUR 416.7 mill. The preliminary segment result amounts to EUR 23.0 mill. (previous year: EUR 20.5 mill.). Sales in the acute segment improved by EUR 12.3 milI. or 5.5 % from EUR 224.3 mill. up to EUR 236.6 mill. The preliminary segment-EBIT for the total year is EUR 1.6 mill. (previous year: EUR -1,2 mill.). In the nursing care business area sales decreased slightly from EUR 15.5 mill up to EUR 15.3 mill.

Further increase in number of staff

In the Group, 10.474 employ were employed as of 31 December 2019, wherein the number of staff in the nursing profession increased significantly compared to the previous year's number. On average for the year the number of full-time employees was 7,431 full-time employees (previous year: 7,226 full-time employees).

Sound financial structure

The equity ratio is 21.2 %, and the net financial debt amounts to EUR 62.5 mill. In addition to cash and cash equivalents of EUR 37.8 mill, the Group has credit lines to finance capacity expansions in MEDICLIN's medical focus areas and thus additional sales.

In the FY 2019 EUR 48.2 mill. (previous year: EUR 49.3 mill.) were invested in non-current assets (gross amount). EUR 17.5 mill. (previous year: EUR 18.5 mill.) was spent on maintenance and repair.

The annual report 2019 will be available under www.mediclin.de in German and English from 26 March 2020.

/

About MEDICLIN AG (Ticker: MED; WKN: 659 510)

MEDICLIN owns 36 clinics, seven nursing care facilities and nine medical care centres. The Group has about 8,500 beds/places and a headcount of about 10,500. With its strong network, MEDICLIN can offer its patients integrated care from the first visit to the doctor to surgery, post-operative rehabilitation and follow-up care at home. Doc-tors, therapists and nurses work together closely to achieve the best results. MEDICLIN plans the care of persons in need in accordance with their individual requirements and personal needs.

MEDICLIN - A company of the Asklepios Group.

 



26.02.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MediClin AG
Okenstra├če 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 984177

 
End of News DGAP News Service

Editor Details

Last Updated: 26-Feb-2020